Christopher J. Searcy
Direktor/Vorstandsmitglied bei BioValve Technologies, Inc.
Profil
Christopher J.
Searcy is currently the Director at BioValve Technologies, Inc. and the Chief Business Officer at TARIS BioMedical LLC.
Previously, he held positions as the Director of Licensing & Development at Pfizer Inc., Vice President of Corporate Development at Nektar Therapeutics, Vice President of Business Development at Cornwall Resources, Inc., and Executive Vice President of Business Development at Valeritas, Inc. He holds a doctorate degree from the University of Minnesota and an MBA from The Wharton School of the University of Pennsylvania.
Aktive Positionen von Christopher J. Searcy
| Unternehmen | Position | Beginn |
|---|---|---|
TARIS BioMedical LLC
 TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Corporate Officer/Principal | 26.07.2011 |
BioValve Technologies, Inc.
 BioValve Technologies, Inc. Pharmaceuticals: MajorHealth Technology BioValve Technologies, Inc. develops new chemical entities for the treatment of central nervous system conditions. It offers various dopamine agonists for treatment of parkinson's disease and schizophrenia; and novel disposable pharmaceutical delivery systems. The company was founded by Robert R. Gonnelli in 1998 and is headquartered in Parsippany, NJ. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Christopher J. Searcy
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | - |
| CORNWALL RESOURCES CORP. | Corporate Officer/Principal | - |
| VALERITAS INC | Corporate Officer/Principal | - |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | - |
Ausbildung von Christopher J. Searcy
| University of Minnesota | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| CORNWALL RESOURCES CORP. | Industrial Services |
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Valeritas, Inc.
 Valeritas, Inc. Medical SpecialtiesHealth Technology Valeritas, Inc. engages in the development and commercialization of drug delivery solutions for the treatment of diabetes. Its product, V-Go wearable insulin delivery device, which enables patients to closely mimic the body’s normal physiologic pattern of insulin delivery by using one type of insulin at a continuous preset basal rate over a 24-hour period and provides on-demand bolus dosing for meals and snacks. The company was founded on August 2, 2006 and is headquartered in Bridgewater, NJ. | Health Technology |
TARIS BioMedical LLC
TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Health Technology |
BioValve Technologies, Inc.
BioValve Technologies, Inc. Pharmaceuticals: MajorHealth Technology BioValve Technologies, Inc. develops new chemical entities for the treatment of central nervous system conditions. It offers various dopamine agonists for treatment of parkinson's disease and schizophrenia; and novel disposable pharmaceutical delivery systems. The company was founded by Robert R. Gonnelli in 1998 and is headquartered in Parsippany, NJ. | Health Technology |
